The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ANACOR PHARMACEUTICALS INC | COM | 032420101 | 125,702 | 1,067,892 | SH | SOLE | 1,067,892 | 0 | 0 | ||
| CARA THERAPEUTICS INC | COM | 140755109 | 38,127 | 2,668,057 | SH | SOLE | 2,668,057 | 0 | 0 | ||
| EVERYDAY HEALTH INC | COM | 300415106 | 37,543 | 4,107,522 | SH | SOLE | 4,107,522 | 0 | 0 | ||
| INOTEK PHARMACEUTICALS CORP | COM | 45780V102 | 26,983 | 2,870,584 | SH | SOLE | 2,870,584 | 0 | 0 | ||
| INTRALINKS HLDGS INC | COM | 46118H104 | 52,148 | 6,290,503 | SH | SOLE | 6,290,503 | 0 | 0 | ||
| NEPHROGENEX INC | COM | 640667101 | 3,559 | 1,052,966 | SH | SOLE | 1,052,966 | 0 | 0 | ||
| REACHLOCAL INC | COM | 75525F104 | 5,424 | 2,570,395 | SH | SOLE | 2,570,395 | 0 | 0 | ||
| RUBICON PROJ INC | COM | 78112V102 | 11,600 | 798,381 | SH | SOLE | 798,381 | 0 | 0 | ||